Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| NCT ID | NCT02748564 |
| Title | Aldesleukin and Pembrolizumab in Treating Patients With Stage III-IV Melanoma |
| Recruitment | Terminated |
| Gender | both |
| Phase | Phase II |
| Variant Requirements | No |
| Sponsors | Rutgers, The State University of New Jersey |
| Indications | |
| Therapies | |
| Age Groups: | child | adult |
| Covered Countries | USA |
| Facility | Status | City | State | Zip | Country | Details |
|---|---|---|---|---|---|---|
| Cardinal Bernardin Cancer Center | Maywood | Illinois | 60153 | United States | Details | |
| Indiana University | Bloomington | Indiana | 46996 | United States | Details | |
| Beth Israel Deaconess Medical Center | Boston | Massachusetts | 02215 | United States | Details | |
| Rutgers Cancer Institute of New Jersey | New Brunswick | New Jersey | 08903 | United States | Details | |
| Roswell Park Comprehensive Cancer Center | Buffalo | New York | 14203 | United States | Details |